Barclays Boosts Allstate (NYSE:ALL) Price Target to $208.00

Allstate (NYSE:ALL) had its target price hoisted by analysts at Barclays from $207.00 to $208.00 in a report released on Wednesday,Benzinga reports. The brokerage currently has an “underweight” rating on the insurance provider’s stock. Barclays‘s target price indicates a potential downside of 3.11% from the company’s previous close.

ALL has been the subject of a number of other research reports. Weiss Ratings raised shares of Allstate from a “buy (b+)” rating to a “buy (a-)” rating in a research note on Monday, March 23rd. Wells Fargo & Company cut their price objective on shares of Allstate from $228.00 to $227.00 and set an “equal weight” rating for the company in a research note on Friday, February 20th. TD Cowen cut shares of Allstate from a “buy” rating to a “hold” rating in a research note on Monday, January 12th. William Blair cut shares of Allstate from an “outperform” rating to a “market perform” rating in a research note on Thursday, December 18th. Finally, Morgan Stanley reaffirmed an “equal weight” rating and issued a $215.00 price objective (down from $245.00) on shares of Allstate in a research note on Tuesday, December 16th. Three analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating, nine have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $238.65.

Allstate Price Performance

ALL stock opened at $214.67 on Wednesday. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.37 and a quick ratio of 0.37. Allstate has a one year low of $184.62 and a one year high of $216.75. The stock has a market cap of $55.72 billion, a PE ratio of 5.62, a P/E/G ratio of 0.43 and a beta of 0.22. The firm has a 50 day simple moving average of $207.49 and a two-hundred day simple moving average of $205.36.

Allstate (NYSE:ALL) last released its quarterly earnings results on Wednesday, February 4th. The insurance provider reported $14.31 EPS for the quarter, topping analysts’ consensus estimates of $8.72 by $5.59. Allstate had a net margin of 15.19% and a return on equity of 39.20%. The business had revenue of $17.35 billion during the quarter, compared to analysts’ expectations of $17.23 billion. During the same quarter in the previous year, the company earned $7.67 EPS. The business’s quarterly revenue was up 5.1% compared to the same quarter last year. On average, analysts predict that Allstate will post 18.74 EPS for the current fiscal year.

Institutional Investors Weigh In On Allstate

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Brighton Jones LLC raised its holdings in Allstate by 60.2% in the 4th quarter. Brighton Jones LLC now owns 6,500 shares of the insurance provider’s stock worth $1,253,000 after purchasing an additional 2,443 shares in the last quarter. Revolve Wealth Partners LLC bought a new position in Allstate in the 4th quarter worth $231,000. Cresset Asset Management LLC raised its holdings in Allstate by 13.5% in the 2nd quarter. Cresset Asset Management LLC now owns 8,245 shares of the insurance provider’s stock worth $1,668,000 after purchasing an additional 979 shares in the last quarter. Bank of Nova Scotia raised its holdings in Allstate by 1.0% in the 2nd quarter. Bank of Nova Scotia now owns 29,575 shares of the insurance provider’s stock worth $5,954,000 after purchasing an additional 296 shares in the last quarter. Finally, WINTON GROUP Ltd bought a new position in Allstate in the 2nd quarter worth $210,000. 76.47% of the stock is currently owned by institutional investors.

Allstate News Summary

Here are the key news stories impacting Allstate this week:

• Positive Sentiment: Wells Fargo raised its price target to $229 (from $227), implying roughly mid‑single‑digit upside and signaling more favorable analyst sentiment toward valuation/earnings — a likely contributor to buying interest today. Wells Fargo price target raise
• Positive Sentiment: Zacks Research nudged up Q1 EPS forecasts for Allstate (slight increases to Q1 estimates and to next‑year EPS), which supports expectations for stronger near‑term earnings and helps explain part of the positive price action. Zacks EPS estimate update
• Neutral Sentiment: Barclays lifted its price target marginally (to $208) but kept an “underweight” rating — this is mixed news (small higher target, but continued caution) and likely had limited net impact on the rally. Barclays price target note
• Neutral Sentiment: Market writeups previewing Allstate’s next earnings release are circulating, keeping investor focus on upcoming results rather than new fundamentals; such coverage can amplify moves but is informational rather than directional. Earnings preview
• Negative Sentiment: Zacks downgraded the stock from “strong‑buy” to “hold” — a visible analyst downgrade that increases risk of selling pressure if other brokers follow. Zacks downgrade
• Negative Sentiment: Allstate faces a retaliation lawsuit after an internal bias report was flagged to HR, raising governance/employment litigation risk that could weigh on sentiment if it escalates. Retaliation suit article
• Negative Sentiment: A driver is publicly challenging Allstate to fully cover a highway accident, a reminder of potential claims exposure and headline risk in the near term. Coverage dispute article

About Allstate

Allstate Corporation is a publicly traded insurance company headquartered in Northbrook, Illinois, and is one of the largest personal lines property and casualty insurers in the United States. Founded in 1931 as a subsidiary of Sears, Roebuck and Co, Allstate has grown into a diversified insurer that serves millions of consumers and businesses through a mix of distribution channels and product offerings.

The company underwrites a broad range of insurance products, with primary emphasis on auto and homeowners coverage.